同步转移性鼻咽癌预后列线图:一项回顾性多中心研究
本研究纳入556例同步转移性鼻咽癌患者,训练队列386例来自广西医科大学附属肿瘤医院,外部验证队列170例来自梧州市红十字会医院和湘潭市中心医院。多因素分析确定M分期、原发灶放疗和免疫治疗与总生存显著相关,构建的列线图C指数为0.743,外部验证区分度和校准度良好,并能有效进行风险分层。
要点
- 多因素分析显示M分期、原发灶放疗和免疫治疗与总生存显著相关。
- 列线图模型C指数为0.743,外部验证区分度和校准度良好。
- 模型可将患者分为高风险和低风险组,两组生存差异显著。
核心结论
- 研究建立的列线图预后模型可有效促进同步转移性鼻咽癌患者的个体化预后预测和风险分层,从而辅助临床医生进行治疗决策。
研究设计与样本
- 回顾性多中心研究,纳入556例同步转移性鼻咽癌患者,训练队列386例来自广西医科大学附属肿瘤医院,外部验证队列170例来自梧州市红十字会医院和湘潭市中心医院。
- 采用Cox比例风险模型确定与总生存相关的因素,并基于识别的预后因素构建列线图预后模型。
- 对模型的区分度和校准度进行评估,并根据计算的风险评分对患者进行分层,采用Kaplan-Meier生存曲线评估分层组间的预后差异。
主要发现
- 多因素分析确定M分期、原发灶放疗和免疫治疗与总生存显著相关。
- 整合这些变量的预后列线图显示出良好的区分度(C指数:0.743)和校准度,并在外部验证队列中得到验证。
- 根据模型得出的风险评分将患者分为高风险组和低风险组,两组生存差异显著。
临床怎么用
- 原文结论认为该列线图预后模型可有效促进个体化预后预测和风险分层,辅助临床医生进行治疗决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with synchronous metastatic nasopharyngeal carcinoma (smNPC) exhibit significant heterogeneity, and clinical prognostic models suitable for this cohort remain limited. We aimed to develop a prognostic prediction tool to facilitate personalised prognostic assessments and inform treatment decisions for these patients. METHODS: This retrospective multicentre study enrolled 556 patients with smNPC. The training cohort comprised 386 patients from Guangxi Medical University Cancer Hospital, while the external validation cohort comprised 170 patients from Wuzhou Red Cross Hospital and Xiangtan Central Hospital. We applied the Cox proportional hazards model to determine factors associated with overall survival (OS). A nomogram prognostic model was developed to predict OS based on the identified prognostic factors. The model's predictive performance was evaluated for discrimination and calibration, and patients were stratified based on their calculated prognostic risk scores. Kaplan-Meier survival curves were employed to assess prognostic differences across the stratified groups. RESULTS: Multivariate analysis identified that M classification, primary tumour radiotherapy, and immunotherapy were significantly associated with OS. A prognostic nomogram integrating these variables exhibited good discrimination (C-index: 0.743) and calibration, which was validated in an external validation cohort. Patients stratified by the model-derived risk scores into high- and low-risk groups showed a significant difference in survival disparity. CONCLUSIONS: We established a nomogram prognostic model that effectively facilitated individualised prognostic prediction and risk stratification in patients with smNPC, thereby assisting clinicians in treatment decision-making.
引用
- Zeng XY, Li Y, Ma J, et al. Prognostic nomogram for synchronous metastatic nasopharyngeal carcinoma: a retrospective multicentre study. Radiat Oncol. 2025. PMID: 40114228. doi:10.1186/s13014-025-02602-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。